Levonordefrin
From Wikipedia, the free encyclopedia
 |
|
|
Levonordefrin
|
|
| Systematic (IUPAC) name | |
| 4-[(1S,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C9H13NO3 |
| Mol. mass | 183.204g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Levonordefrin is a nasal decongestant and a local vasoconstrictor for use in dentistry. It is marketed under the trade name Nordefrin.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
